Moreover, FERMT2 has been confirmed to function as a mechanosensor in human lung cancer tissues, where it interacts with the proline synthesis enzyme PYCR1 in response to alterations in ECM stiffness. This evidence concerns the gene PYCR1 and lung carcinoma.